FourThought Financial Partners LLC Decreases Stake in Doximity, Inc. (NASDAQ:DOCS)

FourThought Financial Partners LLC lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 1.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,680 shares of the company’s stock after selling 433 shares during the quarter. FourThought Financial Partners LLC’s holdings in Doximity were worth $636,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Creative Financial Designs Inc. ADV grew its position in Doximity by 16.7% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after buying an additional 473 shares during the period. Xponance Inc. grew its position in shares of Doximity by 2.7% during the 3rd quarter. Xponance Inc. now owns 19,522 shares of the company’s stock valued at $414,000 after acquiring an additional 508 shares during the period. First Horizon Advisors Inc. increased its stake in shares of Doximity by 111.3% during the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after purchasing an additional 524 shares during the last quarter. Ieq Capital LLC raised its holdings in shares of Doximity by 0.6% in the 3rd quarter. Ieq Capital LLC now owns 99,539 shares of the company’s stock worth $2,112,000 after purchasing an additional 573 shares during the period. Finally, Linden Thomas Advisory Services LLC lifted its stake in Doximity by 2.0% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 40,758 shares of the company’s stock valued at $1,143,000 after purchasing an additional 793 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

DOCS has been the subject of a number of recent research reports. Morgan Stanley reissued an “underweight” rating and issued a $25.00 target price on shares of Doximity in a research report on Tuesday, April 23rd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Bank of America increased their target price on shares of Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 23rd. Truist Financial boosted their price target on shares of Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Friday, February 9th. Finally, SVB Leerink assumed coverage on shares of Doximity in a report on Monday, February 26th. They issued a “market perform” rating and a $32.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $28.82.

Insider Buying and Selling

In other news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction on Monday, April 1st. The shares were sold at an average price of $26.97, for a total transaction of $67,425.00. Following the completion of the sale, the director now directly owns 10,258 shares of the company’s stock, valued at approximately $276,658.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 39.40% of the stock is owned by company insiders.

Doximity Trading Down 0.9 %

Shares of DOCS traded down $0.23 during mid-day trading on Friday, reaching $24.09. 716,659 shares of the stock traded hands, compared to its average volume of 1,438,731. The company has a market cap of $4.49 billion, a price-to-earnings ratio of 36.50, a price-to-earnings-growth ratio of 3.03 and a beta of 1.18. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $36.29. The firm has a fifty day moving average price of $26.45 and a 200 day moving average price of $26.32.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.19 by $0.06. The business had revenue of $135.28 million during the quarter, compared to analysts’ expectations of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. On average, sell-side analysts anticipate that Doximity, Inc. will post 0.72 EPS for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.